Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Genet Dev. 2003 Feb;13(1):77-83.

    Tumor suppression by Ink4a-Arf: progress and puzzles.

    Source

    Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA. lowe@cshl.org

    Abstract

    The two products of the Ink4a-Arf locus, p16(Ink4a) and p19(Arf) (p14(ARF) in humans), are potent tumor suppressors that regulate the activities of the retinoblastoma protein and the p53 transcription factor. These proteins form part of a signaling network that is disrupted in most, if not all, cancer cells. The Ink4a-Arf locus responds to stress signals, limiting cell proliferation and modulating oncogene-induced apoptosis. Recent evidence emerging from mouse tumor models distinguishes the activities of p16(Ink4a) and p19(Arf) in regulating tumor onset and identifies differences in their responsiveness to drugs.

    PMID:
    12573439
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk